Results 11 to 20 of about 138,715 (220)
Age-related macular degeneration [PDF]
Clinical Ophthalmology, 2011 Giuseppe Querques¹, Fernando Onofrio Avellis1,2, Lea Querques1,3, Francesco Bandello³, Eric H Souied¹ ¹Service d'Ophtalmologie, Centre Hospitalier Intercommunal Créteil, Université Paris ...
Querques G +4 more
doaj +6 more sources
Age-related macular degeneration [PDF]
Community Eye Health Journal, 2014 Age-related macular degeneration (AMD) is a disease of the retina that usually develops in people aged 60 years and older. It affects about 8.7% of the world’s population and is the leading cause of blindness among people aged 50 and older in ...
Wanjiku Mathenge
doaj +5 more sources
Pharmacogenetics and Age-Related Macular Degeneration [PDF]
Journal of Ophthalmology, 2011 Pharmacogenetics seeks to explain interpatient variability in response to medications by investigating genotype-phenotype correlations. There is a small but growing body of data regarding the pharmacogenetics of both nonexudative and exudative age ...
Stephen G. Schwartz, Milam A. Brantley
doaj +8 more sources
Age-related Macular Degeneration [PDF]
New England Journal of Medicine, 2006 Age-related macular degeneration is a common cause of blindness. Its incidence is increasing, partly due to the advancing age of the population in North America and Europe, but there is no doubt that the age-adjusted rates are also increasing, which points to some environmental influence.
Amod Gupta, Vishali Gupta, Mangat Dogra
core +8 more sources
Investigating the modulation of genetic effects on late AMD by age and sex: Lessons learned and two additional loci. [PDF]
PLoS ONE, 2018 Late-stage age-related macular degeneration (AMD) is the leading cause of visual impairment in the elderly with a complex etiology. The most important non-modifiable risk factors for onset and progression of late AMD are age and genetic risk factors ...
Thomas W Winkler +8 more
doaj +4 more sources
The role of oxidative stress and antioxidants in the pathogenesis of age-related macular degeneration [PDF]
Clinics, 2011 OBJECTIVE: To investigate the role of oxidant/antioxidant status and protein oxidation in the development of age-related macular degeneration. METHOD: The activities of serum superoxide dismutase and glutathione peroxidase and the levels of serum ...
Zuhal Yildirim +2 more
doaj +5 more sources
Metabolomics and Age-Related Macular Degeneration [PDF]
Metabolites, 2018 Age-related macular degeneration (AMD) leads to irreversible visual loss, therefore, early intervention is desirable, but due to its multifactorial nature, diagnosis of early disease might be challenging.
Connor N. Brown +5 more
doaj +7 more sources
Age-related macular degeneration: current treatments [PDF]
Clinical Ophthalmology, 2009 Jean Pierre Hubschman, Shantan Reddy, Steven D SchwartzJules Stein Eye Institute, Department of Ophthalmology, University of California, David Geffen School of Medicine, Los Angeles, California, USAPurpose: Although important progress has been made in ...
Jean Pierre Hubschman +2 more
doaj +5 more sources
Prevention of age-related macular degeneration [PDF]
International Ophthalmology, 2010 Age-related macular degeneration (AMD) is one of the leading causes of blindness in the developed world. Although effective treatment modalities such as anti-VEGF treatment have been developed for neovascular AMD, there is still no effective treatment for geographical atrophy, and therefore the most cost-effective management of AMD is to start with ...
Chan, CWN, Koo, SCY, Wong, IYH
openaire +9 more sources
Choriocapillaris in Age-Related Macular Degeneration
Türk Oftalmoloji DergisiAge-related macular degeneration (AMD) is a multifactorial disease characterized by progressive alterations of different retinal structures ultimately leading to vision loss.
Giovanni Neri +6 more
doaj +3 more sources